Roswell Park

Buffalo, New York 14263

5 studies enrolling now · 28 studies all time

What they study most

Acute Myeloid Leukemia, Advanced Solid Tumor, Advanced Solid Tumors, Allogeneic Hematopoietic Stem Cell Transplantation, Ampullary Cancer, Biliary Tract Cancer, Breast Cancer Metastatic, CLL/SLL, Carcinoma, Non-Small-Cell Lung, Cholangiocarcinoma, Chronic Myelomonocytic Leukemia, Clear Cell Renal Cell Carcinoma

Studies at this site

• Phase 1b/2 Study of Decitabine and Venetoclax in Combination With the Targeted Mutant IDH1 Inhibitor Olutasidenib — Recruiting now
• Influence of Authorized Smokeless Tobacco Product Modified Risk Claims I: Consumer Product Demand — Recruiting now
• Influence of Authorized Smokeless Tobacco Product Modified Risk Claims II: Laboratory Assessment of Sensory and Subjective Effects — Recruiting now
• A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors — Recruiting now
• A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer — Recruiting now
• A Study to Evaluate the Safety and Efficacy of OPB-101 in Platinum-resistant Ovarian Cancer — Recruiting now
• Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid Tumors — Completed
• Autologous CD19 CAR-T Cell Therapy (SYNCAR-001) + Orthogonal IL-2 (STK-009) in Subjects With CD19+ Hematologic Malignancies — Running, not enrolling
• A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002) — Running, not enrolling
• Study of Crenolanib vs Midostaurin Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed FLT3 Mutated AML — Completed
• FT576 in Subjects With Multiple Myeloma — Completed
• Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments — Running, not enrolling
• Close Assessment and Testing for Chronic Graft Versus Host Disease, CATCH Study — Completed
• CAB-AXL-ADC Safety and Efficacy Study in Adults With NSCLC — Completed
• A Study of Rucaparib Versus Physician's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency — Completed
• A Study to Assess Overall Response Rate by Inducing an Inflammatory Phenotype in Metastatic BReast cAnCEr With the Oncolytic Reovirus PeLareorEp in CombinaTion With Anti-PD-L1 Avelumab and Paclitaxel - BRACELET-1 Study — Running, not enrolling
• CAB-ROR2-ADC Safety and Efficacy Study in Patients With TNBC or Head & Neck Cancer (Ph1) and NSCLC or Melanoma (Ph2) — Completed
• Guadecitabine Extension Study — Stopped early
• Study of ASTX727 vs IV Decitabine in Participants With MDS, CMML, and AML — Completed
• Effect of Food on Blood Levels of ASTX727 — Completed
• A Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency — Completed
• A Study of TAK-659 in Combination With Nivolumab in Participants With Advanced Solid Tumors — Stopped early
• Prospective Cohort for the Evaluation of Biomarkers Following HCT (BMT CTN 1202) — Completed
• Study of Gene Modified Donor T Cell Infusion in Patients With Recurrent Disease After Allogeneic Transplant — Running, not enrolling
• Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD) — Completed
• Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Etoposide and Carboplatin in Extensive Stage Small Cell Lung Cancer (SCLC) — Completed
• Research Tissue Bank — Completed
• A Study of BMS-863233 in Patients With Hematologic Cancer — Stopped early